Aclaris Therapeutics, Inc. (ACRS)
3.27
+0.06
(+1.87%)
USD |
NASDAQ |
Dec 10, 16:00
3.28
+0.01
(+0.31%)
After-Hours: 20:00
Aclaris Therapeutics Market Cap: 354.29M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 8.974B |
| Puma Biotechnology, Inc. | 281.69M |
| Xencor, Inc. | 1.225B |
| Vivos Therapeutics, Inc. | 19.68M |
| CEL-SCI Corp. | 19.82M |
Market Cap Related Metrics
| PS Ratio | 24.04 |
| PEG Ratio | -0.0143 |
| Price to Book Value | 2.95 |
| Price | 3.27 |
| Earnings Yield | -42.24% |
| PEGY Ratio | -0.0143 |